000 01578 a2200373 4500
005 20250515022757.0
264 0 _c20060814
008 200608s 0 0 eng d
022 _a0022-3565
024 7 _a10.1124/jpet.106.101477
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPark, Sung-Sik
245 0 0 _aN6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cJul 2006
300 _a124-31 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aCardiotonic Agents
_xpharmacology
650 0 4 _aGlycogen Synthase Kinase 3
_xantagonists & inhibitors
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aMale
650 0 4 _aMitochondrial Membrane Transport Proteins
_xantagonists & inhibitors
650 0 4 _aMitochondrial Permeability Transition Pore
650 0 4 _aMyocardial Reperfusion Injury
_xenzymology
650 0 4 _aRats
650 0 4 _aRats, Wistar
700 1 _aZhao, Hong
700 1 _aJang, Yeongho
700 1 _aMueller, Robert A
700 1 _aXu, Zhelong
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 318
_gno. 1
_gp. 124-31
856 4 0 _uhttps://doi.org/10.1124/jpet.106.101477
_zAvailable from publisher's website
999 _c16216846
_d16216846